To enhance your user experience on our website, this site uses cookies.
If you continue to browse, you accept the use of cookies on our site.
See our Privacy Policy
for more information.
Studies have shown hydrogel-based platforms can effectively expand effector T cells in vivo, demonstrating their potential for enhancing CD8+ T cell responses and anti-tumor efficacy, making them crucial for immunotherapy research.